Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6125942 | Seminars in Immunology | 2011 | 7 Pages |
Abstract
Dendritic cells (DCs) were discovered in 1973 by Ralph Steinman as a previously undefined cell type in the mouse spleen and are now recognized as a group of related cell populations that induce and regulate adaptive immune responses. Studies of the past decade show that, both in mice and humans, DCs are composed of subsets that differ in their localization, phenotype, and functions. These progresses in our understanding of DC biology provide a new framework for improving human health. In this review, we discuss human DC subsets in the context of their medical applications, with a particular focus on DC targeting.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Hideki Ueno, Eynav Klechevsky, Nathalie Schmitt, Ling Ni, Anne-Laure Flamar, Sandra Zurawski, Gerard Zurawski, Karolina Palucka, Jacques Banchereau, SangKon Oh,